Investors Snag NTLA Even Cheaper Than Its Secondary Stock Offering
December 02, 2022 at 10:32 AM EST
Looking back to 2 days ago, Intellia Therapeutics Inc (NTLA) priced a 6,550,219 share secondary stock offering at $45.80 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time..